Skip to main content
. Author manuscript; available in PMC: 2018 Nov 28.
Published in final edited form as: Nat Genet. 2018 May 28;50(6):834–848. doi: 10.1038/s41588-018-0127-7

Table 1.

Results of the meta-analysis of CREAM and 23andMe for the previously-identified loci and a subset of the newly-identified loci, and replication in UK Biobank

a Replication of the HapMap II index variants for refractive error per locus in the Stage 3 meta-analysis
SNP Chr Position Nearest Loci And
Gene(s)
Effect
Allele
Other
Allele
EAF
EUR
EAF
ASN
Z-score Direction P value HetISq HetPVal Sample
Size (N)
HapMap II
Discovery (2013)
Category P value
Replication
rs10500355 16 7459347 RBFOX1 A T 0.354 0.133 −13.73 −− 6.49E-43 9.1 2.93E-07 160,139 Kiefer et al. & Verhoeven et al. I 2.50E-48
rs11145465 9 71766593 TJP2 A C 0.212 NA −9.55 −− 1.35E-21 46.3 0.1722 153,174 Kiefer et al. & Verhoeven et al. I 1.00E-10
rs11178469 12 71275137 PTPRR T C 0.752 0.638 −7.40 −− 1.33E-13 0 0.6989 160,139 Verhoeven et al. II (CREAM) 2.60E-04
rs11602008 11 40149305 LRRC4C A T 0.822 0.749 13.98 ++ 2.12E-44 22.5 1.56E-10 157,505 Kiefer et al. II (23andMe) 2.90E-47
rs12193446 6 129820038 BC035400, LAMA2 A G 0.906 NA −19.43 −− 4.21E-84 16.8 5.72E-15 150,269 Kiefer et al. & Verhoeven et al. I 4.60E-106
rs1550094 2 233385396 CHRNG, PRSS56 A G 0.701 0.705 12.74 ++ 3.64E-37 26.3 0.003 159,422 Kiefer et al. & Verhoeven et al., Kiefer et al. I 4.10E-59
rs1649068 10 60304864 BICC1 A C 0.475 0.504 −9.44 −− 3.77E-21 0 0.712 160,144 Verhoeven et al. I 7.50E-11
rs17382981 10 94953258 CYP26A1,MYOF T C 0.417 0.190 −6.31 −− 2.72E-10 67.9 0.077 155,332 Verhoeven et al. II (CREAM) 4.10E-07
rs17428076 2 172851936 HAT1, METAP1D C G 0.768 0.854 −8.18 −− 2.77E-16 0 0.003 160,151 Kiefer et al. II (23andMe) 7.50E-08
rs1858001 1 207488004 C4BPA,CD55 C G 0.676 0.415 7.28 ++ 3.45E-13 59.6 0.020 160,149 Verhoeven et al. II (CREAM) 6.70E-20
rs1954761 11 105596885 GRIA4 T C 0.371 0.377 −8.40 −− 4.57E-17 0 0.911 160,122 Verhoeven et al. I 1.20E-16
rs2155413 11 84634790 DLG2 A C 0.482 0.655 −7.76 −− 8.85E-15 0 2.99E-04 159,504 Kiefer et al. II (23andMe) 1.10E-17
rs235770 20 6761765 BMP2 T C 0.372 0.388 −5.93 −− 3.11E-09 0 0.547 157,521 Verhoeven et al. II (23andMe) 4.80E-11
rs2573081 2 178828507 PDE11A C G 0.524 0.538 8.21 ++ 2.18E-16 47.6 0.167 160,126 Kiefer et al. II (23andMe) 1.60E-29
rs2753462 14 60850703 JB175233, C14orf39 C G 0.296 0.568 −6.49 −− 8.37E-11 73.9 0.050 157,352 Verhoeven et al. II (CREAM) 2.00E-15
rs2855530 14 54421917 BMP4 C G 0.507 0.474 −8.58 −− 9.87E-18 41.7 0.190 160,092 Kiefer et al. I 4.80E-22
rs2908972 17 11407259 SHISA6 A T 0.415 0.484 −11.13 −− 9.46E-29 23 0.254 160,123 Kiefer et al. & Verhoeven et al. I 6.10E-29
rs3138141 12 56115778 BLOC1S1-RDH5,RDH5 A C 0.214 0.147 13.80 ++ 2.46E-43 3.2 5.05E-07 157,531 Kiefer et al. & Verhoeven et al. I 2.30E-56
rs4687586 3 53837971 CACNA1D C G 0.691 NA −6.55 −− 5.86E-11 0 0.605 150,217 Verhoeven et al. III 1.60E-08
rs4793501 17 68718734 KCNJ2, BC039327 T C 0.575 0.444 −7.21 −− 5.53E-13 0 0.592 160,150 Verhoeven et al. II (CREAM) 3.70E-12
rs524952 15 35005886 GOLGA8B, GJD2 A T 0.475 0.507 −17.08 −− 2.28E-65 67.2 0.015 160,150 Kiefer et al. & Verhoeven et al. I 1.60E-103
rs56075542 2 146882415 BC040861, PABPC1P2 T G 0.552 0.472 −8.99 −− 2.39E-19 13.9 0.001 159,478 Kiefer et al. II (23andMe) 1.30E-18
rs62070229 17 31227593 MYO1D, TMEM98 A G 0.807 0.874 8.58 ++ 9.64E-18 0 0.416 156,570 Verhoeven et al. I 1.30E-18
rs6495367 15 79375347 RASGRF1 A G 0.408 0.399 −10.20 −− 1.95E-24 0 0.667 160,144 Kiefer et al. & Verhoeven et al. I 7.20E-37
rs7042950 9 77149837 RORB A G 0.732 0.392 6.80 ++ 1.07E-11 0 0.912 160,153 Verhoeven et al. III 2.90E-18
rs72621438 8 60178580 SNORA51, CA8 C G 0.642 0.609 −13.14 −− 2.03E-39 38.4 0.006 160,128 Kiefer et al. & Verhoeven et al. I 1.80E-49
rs745480 10 85986554 LRIT2,LRIT1 C G 0.511 0.418 8.31 ++ 9.26E-17 67.3 0.081 159,504 Kiefer et al. II (23andMe) 8.20E-18
rs7624084 3 141093285 ZBTB38 T C 0.568 0.633 −8.81 −− 1.24E-18 18.5 0.018 160,151 Kiefer et al. II (23andMe) 6.50E-17
rs7662551 4 80537638 LOC100506035, PCAT4 A G 0.723 0.558 8.53 ++ 1.47E-17 19.4 0.265 160,147 Verhoeven et al. I 6.00E-12
rs7692381 4 81903049 C4orf22, BMP3 A G 0.763 0.630 9.40 ++ 5.55E-21 0 0.013 160,134 Kiefer et al. I 7.50E-13
rs7744813 6 73643289 KCNQ5 A C 0.591 0.602 −14.56 −− 5.43E-48 35 0.001 160,091 Kiefer et al. & Verhoeven et al. I 1.00E-75
rs7829127 8 40726394 ZMAT4 A G 0.792 0.897 −10.91 −− 1.02E-27 15.9 2.77E-04 160,132 Kiefer et al. & Verhoeven et al. II (23andMe) 3.10E-22
rs7895108 10 79061458 KCNMA1 T G 0.351 0.118 −8.87 −− 7.56E-19 32.8 0.021 160,140 Kiefer et al. II (23andMe) 1.10E-27
rs79266634 16 7309047 RBFOX1 C G 0.093 0.115 −5.93 −− 3.00E-09 0 0.561 156,268 Kiefer et al. & Verhoeven et al. III 1.50E-08
rs837323 13 101175664 PCCA T C 0.512 0.762 6.32 ++ 2.65E-10 35.6 0.213 160,142 Verhoeven et al. II (23andMe) 5.30E-16
rs9517964 13 100717833 ZIC2,PCCA T C 0.589 0.786 8.42 ++ 3.68E-17 0 0.020 160,121 Kiefer et al. II (23andMe) 3.40E-20
b Subset of the new loci harboring the smallest p-values for refractive error in the Stage 3 meta-analysis
SNP Chr Position Nearest Loci And
Gene(s)
Effect
Allele
Other
Allele
EAF
EUR
EAF ASN Z-score Direction P value HetISq HetPVal Sample
Size (N)
Category P value
Replication
rs36024104 14 42294993 LRFN5 A G 0.823 NA 9.09 ++ 9.86E-20 15.9 0.01414 152,585 II (23andMe) 2.20E-12
rs7456039 7 6901710 CCZ1B, LOC100131257 C G 0.183 NA 8.82 ++ 1.18E-18 42.1 3.79E-12 121,337 II (23andMe) 6.50E-01
rs1556867 1 164213686 5S_rRNA, PBX1 T C 0.264 0.494 −8.81 −− 1.29E-18 71.1 0.06266 160,155 II (23andMe) 4.20E-17
rs12667032 7 154406581 DPP6 A G 0.152 0.317 7.99 ++ 1.31E-15 82.3 1.02E-11 130,790 II (23andMe) 2.10E-01
rs2225986 1 200311910 LINC00862 A T 0.381 0.169 −7.96 −− 1.68E-15 40.2 0.196 160,152 II (23andMe) 7.50E-17
rs1207782 6 22059967 LINC00340 T C 0.577 0.265 −7.92 −− 2.47E-15 0 0.8946 160,149 I 4.90E-13
rs72826094 10 114801488 TCF7L2 A T 0.799 0.838 7.88 ++ 3.20E-15 64.5 0.09323 156,825 II (23andMe) 4.90E-02
rs297593 2 157363743 GPD2 T C 0.286 0.257 −7.82 −− 5.45E-15 0 0.5285 159,461 II (23andMe) 7.80E-11
rs5442 12 6954864 GNB3 A G 0.068 NA −7.82 −− 5.48E-15 8.8 0.03693 146,217 II (23andMe) 1.20E-33
rs10880855 12 46144855 ARID2 T C 0.507 0.464 −7.78 −− 7.35E-15 0 0.9683 160,144 I 4.80E-08
rs12405776 1 242431557 PLD5 T C 0.220 0.521 7.75 ++ 9.52E-15 64.9 3.56E-10 153,784 II (23andMe) 1.50E-01
rs2150458 21 47377296 PCBP3, COL6A1 A G 0.455 0.641 7.74 ++ 1.04E-14 55.7 0.1329 160,151 II (23andMe) 1.80E-13
rs12898755 15 63574641 APH1B A G 0.245 0.456 7.53 ++ 4.98E-14 7.9 0.2974 159,506 II (23andMe) 1.40E-16
rs7122817 11 117657679 DSCAML1 A G 0.507 0.662 7.51 ++ 5.73E-14 73.8 0.05077 160,147 II (23andMe) 1.10E-10
rs10511652 9 18362865 SH3GL2, ADAMTSL1 A G 0.416 0.445 7.36 ++ 1.91E-13 44.8 0.1782 160,149 II (23andMe) 3.50E-18
rs11101263 10 49414181 FRMPD2 T C 0.258 0.105 −7.33 −− 2.33E-13 0 0.3477 160,155 II (23andMe) 2.20E-13
rs11118367 1 219790221 LYPLAL1 T C 0.482 0.630 −7.29 −− 3.16E-13 0 0.8576 160,141 III 1.20E-13
rs9395623 6 50757699 TFAP2D, TFAP2B A T 0.315 0.381 7.25 ++ 4.16E-13 0 0.9579 160,151 III 2.20E-10
rs284816 8 53362145 ST18, FAM150A A G 0.163 0.198 −7.21 −− 5.52E-13 0 0.9242 160,140 III 1.60E-08
rs12965607 18 47391025 MYO5B T G 0.857 0.923 7.07 ++ 1.52E-12 20.8 0.01674 157,604 II (23andMe) 8.10E-16
rs7747 4 80827062 ANTXR2 T C 0.202 0.093 7.03 ++ 2.05E-12 5.4 0.01267 150,327 II (23andMe) 7.70E-16
rs12451582 17 54734643 NOG, C17orf67 A G 0.369 0.308 7.02 ++ 2.22E-12 0 0.5925 160,155 II (23andMe) 8.80E-18
rs80253120 17 14138507 CDRT15 T C 0.626 0.723 6.97 ++ 3.25E-12 58.6 0.12 156,054 II (23andMe) 7.20E-11
22:23069851:I 22 23069851 DKFZp667J0810 ATG A 0.084 0.1582 6.95 −+ 3.56E-12 98.5 4.80E-16 120,481 II (23andMe) 9.30E-01
rs7968679 12 9313304 PZP A G 0.700 0.894 6.95 ++ 3.65E-12 0 0.01951 160,076 II (23andMe) 4.20E-10
rs11202736 10 90142203 RNLS A T 0.717 0.762 −6.92 −− 4.53E-12 0 0.4007 160,150 II (23andMe) 9.40E-07
rs11088317 21 16574122 NRIP1, USP25 T C 0.287 0.299 −6.90 −− 5.38E-12 72.5 0.05657 160,116 II (23andMe) 6.50E-06
rs10853531 18 42824449 SLC14A2 A G 0.200 0.182 6.88 ++ 5.89E-12 0 0.6755 160,104 III 2.60E-10
rs72655575 8 60556509 SNORA51, CA8 A C 0.201 0.124 6.87 ++ 6.54E-12 0 0.8811 156,566 I 7.10E-07
rs12998513 2 242879499 CXXC11,AK097934 A G 0.880 0.676 −6.86 +− 7.15E-12 65.2 4.51E-14 117,611 II (23andMe) 7.80E-01
rs1790165 11 131928971 NTM A C 0.411 0.283 6.85 ++ 7.17E-12 0 0.003708 160,131 II (23andMe) 1.80E-10
rs511217 11 30029948 METTL15, KCNA4 A T 0.738 0.729 −6.79 −− 1.10E-11 0 0.3626 160,143 II (23andMe) 1.40E-17
rs1150687 6 28162469 ZNF192P1, TRNA_Ser T C 0.619 0.504 6.78 ++ 1.17E-11 56.2 0.131 159,448 II (23andMe) 3.10E-10
rs56055503 16 80532694 MAF, DYNLRB2 A G 0.751 0.539 −6.72 −− 1.83E-11 0 0.8407 160,145 II (23andMe) 8.00E-06
rs9681162 3 8194734 AK124857, LMCD1-AS1 T C 0.680 0.437 6.70 ++ 2.10E-11 63 0.1002 160,152 II (23andMe) 6.30E-13
rs11589487 1 61342229 AK097193, BC030753 A G 0.445 0.089 6.67 ++ 2.64E-11 34.6 0.2163 160,143 II (23andMe) 2.20E-10

We identified 140 loci for refractive error with genome-wide significance (P < 5 × 10−8) on the basis the meta-analyses of the genome-wide single-variant linear regressions performed in 160,420 participants of mixed ancestries (CREAM-ASN, CREAM-EUR and 23andMe). Shown are the replication of the previously found loci from HapMap II and a subset of the new loci harboring the smallest P values. For each locus, represented by an index variant (the variant with smallest p-value in that locus), Effect Allele, Other Allele, effect allele frequencies per ancestry (EAF AZN and EAF EUR), effect size (Z-score), direction of the effect (Direction), the P value, heterogeneity I square (HetISq), heterogeneity P value (HetPval), Sample Size (N), Category (I = both GWS in Stage 1 and 2, 2=one of two cohorts (CREAM or 23andMe) GWS, 3= both not GWS in Stage 1 or 2) and P value of the replication in UK Biobank are shown (Full table: Supplementary Table 2). Chr, chromosome; EAF, effect allele frequency; ASN, Asian; EUR, European; GWS, genome wide significant.